APA (7th ed.) Citation

Pope, J. E., Patel, J., Saffore, C. D., Fang, S., Rasymas, A., Liazoghli, D., & Ziouzina, O. (2026). Real-World Upadacitinib Persistence and Clinical Outcomes Among Canadian Patients with Inflammatory Arthritis from a Patient Support Program: The UPRAISE Study. Rheumatology & Therapy, 13(4), 1075. https://doi.org/10.1007/s40744-026-00859-w

Chicago Style (17th ed.) Citation

Pope, Janet E., Jayeshkumar Patel, Christopher D. Saffore, Siran Fang, Al Rasymas, Dalinda Liazoghli, and Olga Ziouzina. "Real-World Upadacitinib Persistence and Clinical Outcomes Among Canadian Patients with Inflammatory Arthritis from a Patient Support Program: The UPRAISE Study." Rheumatology & Therapy 13, no. 4 (2026): 1075. https://doi.org/10.1007/s40744-026-00859-w.

MLA (9th ed.) Citation

Pope, Janet E., et al. "Real-World Upadacitinib Persistence and Clinical Outcomes Among Canadian Patients with Inflammatory Arthritis from a Patient Support Program: The UPRAISE Study." Rheumatology & Therapy, vol. 13, no. 4, 2026, p. 1075, https://doi.org/10.1007/s40744-026-00859-w.